Insurance Barriers and Inequalities in Health Care Access: Evidence from Dual Practice

Overview

Journal Health Econ Rev

Publisher Biomed Central

Specialty Public Health

Date 2024 Mar 21

PMID 38512590

Authors

Eva Goetjes

Katharina E Blankart

Affiliations

Soon will be listed here.

Abstract

Background: We investigate access disparities in pharmaceutical care among German patients with type 2 diabetes, focusing on differences between public and private health insurance schemes. The primary objectives include investigating whether patients with private health insurance experience enhanced access to antidiabetic care and analyzing whether the treatment received by public and private patients is influenced by the practice composition, particularly the proportion of private patients.

Methods: We estimate fixed effect regression models, to isolate the effect of insurance schemes on treatment choices. We utilize data from a prescriber panel comprising 681 physicians collectively serving 68,362 patients undergoing antidiabetic treatments.

Results: The analysis reveals a significant effect of the patient's insurance status on antidiabetic care access. Patients covered by private insurance show a 10-percentage-point higher likelihood of receiving less complex treatments compared to those with public insurance. Furthermore, the composition of physicians' practices plays a crucial role in determining the likelihood of patients receiving less complex treatments. Notably, the most pronounced disparities in access are observed in practices mirroring the regional average composition.

Conclusions: Our findings underscore strategic physician navigation across diverse health insurance schemes in ambulatory care settings, impacting patient access to innovative treatments.

References

Fischer K, Koch T, Kostev K, Stargardt T . The impact of physician-level drug budgets on prescribing behavior. Eur J Health Econ. 2017; 19(2):213-222. DOI: 10.1007/s10198-017-0875-9. View

Ehlert A, Oberschachtsiek D . Why do German physicians reject managed care?. Int J Health Plann Manage. 2018; 34(1):87-99. DOI: 10.1002/hpm.2575. View

Nathan D, Buse J, Davidson M, Ferrannini E, Holman R, Sherwin R . Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2008; 32(1):193-203. PMC: 2606813. DOI: 10.2337/dc08-9025. View

Frank R, Zeckhauser R . Custom-made versus ready-to-wear treatments: behavioral propensities in physicians' choices. J Health Econ. 2007; 26(6):1101-27. DOI: 10.1016/j.jhealeco.2007.08.002. View

Moller D . New drug targets for type 2 diabetes and the metabolic syndrome. Nature. 2001; 414(6865):821-7. DOI: 10.1038/414821a. View

Feng Y, Gravelle H . Details matter: Physician responses to multiple payments for the same activity. Soc Sci Med. 2019; 235:112343. DOI: 10.1016/j.socscimed.2019.05.048. View

Ab Rahman N, Lim M, Thevendran S, Ahmad Hamdi N, Sivasampu S . Medication Regimen Complexity and Medication Burden Among Patients With Type 2 Diabetes Mellitus: A Retrospective Analysis. Front Pharmacol. 2022; 13:808190. PMC: 8978326. DOI: 10.3389/fphar.2022.808190. View

Atella V, Belotti F, Depalo D . Drug therapy adherence and health outcomes in the presence of physician and patient unobserved heterogeneity. Health Econ. 2017; 26 Suppl 2:106-126. DOI: 10.1002/hec.3570. View

Glied S, Graff Zivin J . How do doctors behave when some (but not all) of their patients are in managed care?. J Health Econ. 2002; 21(2):337-53. DOI: 10.1016/s0167-6296(01)00131-x. View

10.

Donnan P, MacDonald T, Morris A . Adherence to prescribed oral hypoglycaemic medication in a population of patients with Type 2 diabetes: a retrospective cohort study. Diabet Med. 2002; 19(4):279-84. DOI: 10.1046/j.1464-5491.2002.00689.x. View

11.

Uzoigwe C, Liang Y, Whitmire S, Paprocki Y . Semaglutide Once-Weekly Persistence and Adherence Versus Other GLP-1 RAs in Patients with Type 2 Diabetes in a US Real-World Setting. Diabetes Ther. 2021; 12(5):1475-1489. PMC: 8099966. DOI: 10.1007/s13300-021-01053-7. View

12.

Cutler D, Skinner J, Stern A, Wennberg D . Physician Beliefs and Patient Preferences: A New Look at Regional Variation in Health Care Spendingf. Am Econ J Econ Policy. 2020; 11(1):192-221. PMC: 7444804. DOI: 10.1257/pol.20150421. View

13.

Socha K, Bech M . Physician dual practice: a review of literature. Health Policy. 2010; 102(1):1-7. DOI: 10.1016/j.healthpol.2010.10.017. View

14.

van Dieren S, Beulens J, van der Schouw Y, Grobbee D, Neal B . The global burden of diabetes and its complications: an emerging pandemic. Eur J Cardiovasc Prev Rehabil. 2010; 17 Suppl 1:S3-8. DOI: 10.1097/01.hjr.0000368191.86614.5a. View

15.

Dailey G, Kim M, Lian J . Patient compliance and persistence with anti-hyperglycemic therapy: evaluation of a population of type 2 diabetic patients. J Int Med Res. 2002; 30(1):71-9. DOI: 10.1177/147323000203000111. View

16.

Ahammer A, Schober T . Exploring variations in health-care expenditures-What is the role of practice styles?. Health Econ. 2020; 29(6):683-699. PMC: 7187477. DOI: 10.1002/hec.4011. View

17.

Hullegie P, Klein T . The effect of private health insurance on medical care utilization and self-assessed health in Germany. Health Econ. 2010; 19(9):1048-62. DOI: 10.1002/hec.1642. View

18.

Matthay E, Hagan E, Gottlieb L, Tan M, Vlahov D, Adler N . Alternative causal inference methods in population health research: Evaluating tradeoffs and triangulating evidence. SSM Popul Health. 2020; 10:100526. PMC: 6926350. DOI: 10.1016/j.ssmph.2019.100526. View

19.

Sundmacher L, Ozegowski S . Regional distribution of physicians: the role of comprehensive private health insurance in Germany. Eur J Health Econ. 2015; 17(4):443-51. DOI: 10.1007/s10198-015-0691-z. View

20.

Roebuck M, Liberman J, Gemmill-Toyama M, Brennan T . Medication adherence leads to lower health care use and costs despite increased drug spending. Health Aff (Millwood). 2011; 30(1):91-9. DOI: 10.1377/hlthaff.2009.1087. View